A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages

  Votanopoulos, Konstantinos ^a   Ihemelandu, Chukwuemeka ^a   Shen, Perry ^a   Stewart, John ^a   Russell, Gregory ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hematologic toxicity; HIPEC; Mitomycin C; Oxaliplatin

Indexed keywords

MITOMYCIN C; OXALIPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SPLENECTOMY;

ADULT; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; BLOOD PLATELETS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MITOMYCIN; NEUTROPHILS; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84870709925     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.01.015     Document Type: Article

References (33)

1. D. Elias, and J.F. Ouellet Intraperitoneal chemohyperthermia: Rationale, technique, indications and results Surg Oncol Clin North Am 10 2001 915
2. P.H. Sugarbaker, W. Cuniffe, and J.F. Belliveau Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy Reg Cancer Treat 1 1988 66
3. D. Elias, F. Blot, and A. El Otmany Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 92 2001 71
4. R.L. Dedrick, and M.F. Flessner Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure J Natl Cancer Inst 89 1997 480 487
5. R.L. Dedrick Interspecies scaling of regional drug delivery J Pharm Sci 75 1986 1047
6. M.F. Flessner, R.L. Dedrick, and J.S. Schultz A distributed model of peritoneal-plasma transport: theoretical considerations Am J Physiol 246 1984 R597
7. T.D. Yan, D. Black, and R. Savady Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 2006 4011
8. T. Kuzuya, M. Yamauchi, and A. Ito Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy J Pharm Pharmacol 46 1994 685
9. M.H. Katz, and R.M. Barone The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies Surg Oncol Clin North Am 12 2003 673
10. P.H. Sugarbaker, R. Alderman, and G. Edwards Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol 13 2006 635
11. K.J. Schnake, P.H. Sugarbaker, and D. Yoo Neutropenia following perioperative intraperitoneal chemotherapy Tumori 85 1999 41
12. J.H. Stewart, P. Shen, G. Russell, J. Fenstermaker, L. McWilliams, F.M. Coldrun, K.E. Levine, B.T. Jones, and E.A. Levine A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers Ann Surg Oncol 15 2008 2137
13. D.M. Elias, and L. Sideris Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis Surg Oncol Clin N Am 12 2003 755
14. D. Elias, M. Bonnay, and J.M. Puizillou Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution Ann Oncol 13 2002 267
15. J.H. Stewart 4th, P. Shen, and G. Russell A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers Ann Surg Oncol 15 2008 2137
16. P. Shen, J.H. Stewart 4th, and E.A. Levine Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale Curr Probl Cancer 33 2009 125
17. National Cancer Institute. CTEP: NCI Guidance on CTC Terminology Applications. Bethesda, MD: National Cancer Institute; 2009. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm.
18. V.J. Verwaal, S. van Ruth, and E. de Bree Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 2003 3737
19. S.A. Butterworth, O.N. Panton, and D.J. Klaassen Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei Am J Surg 183 2002 529
20. R. Loungnarath, S. Causeret, and N. Bossard Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study Dis Colon Rectum 48 2005 1372
21. M. Deraco, D. Baratti, and M.G. Inglese Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 2004 393
22. R.M. Smeenk, V.J. Verwaal, and F.A. Zoetmulder Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei. A report of 103 procedures Eur J Surg Oncol 32 2006 186
23. O. Glehen, D. Osinsky, and E. Cotte Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol 10 2003 863
24. P.H. Sugarbaker, R. Alderman, and G. Edwards Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol 13 2006 635
25. L.A. Lambert, T.S. Armstrong, and J.J. Lee Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C Ann Surg Oncol 16 2009 2181
26. D. Elias, M. Bonnay, and J.M. Puizillou Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: Pharmacokinetic and tissue distribution Ann Oncol 13 2002 267
27. D. Elias, A. El Otmany, and M. Bonnay Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions, after complete resection of peritoneal carcinomatosis Oncology 63 2002 346
28. D. Elias, L. Sideris, and M. Pocard Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients Ann Oncol 15 2004 781
29. W.P. Ceelen, M. Peeters, and P. Houtmeyers Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis Ann Surg Oncol 15 2008 535
30. N.M. Rueth, S.E. Murray, and S.J. Huddleston Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: Oxaliplatin versus mitomycin C Ann Surg Oncol 18 2011 174
31. R.D. Becher, P. Shen, and J. Stewart Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy J Gastrointest Oncol 2 2011 70
32. M.A. Bidus, T.C. Krivak, and R. Howard Hematologic changes after splenectomy for cytoreduction: Implications for predicting infection and effects on chemotherapy Int J Gynecol Cancer 16 2006 1957
33. S. Van Ruth, R.A. Mathot, and R.W. Sparidans Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy Clin Pharmacokinet 43 2004 131